Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
61,895
-
Share change
-
-544
-
Total reported value
-
$2,785,275
-
Price per share
-
$45.00
-
Number of holders
-
1
-
Value change
-
-$24,480
-
Number of sells
-
1
Institutional Holders of PROTAGONIST THERAPEUTICS INC - COM as of Q3 2024
As of 30 Sep 2024,
PROTAGONIST THERAPEUTICS INC - COM was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
61,895 shares.
The largest 1 holders included
Twin Lakes Capital Management, LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.